Breast

Papers
(The TQCC of Breast is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain1592
A multicenter retrospective study of early cardiac toxicity in operable breast cancer patients receiving concurrent dual or mono anti-HER2 therapy with postoperative radiation therapy155
Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer116
A multidisciplinary approach to optimizing care of patients treated with alpelisib108
Patient-reported outcomes in bilateral prophylactic mastectomy with breast reconstruction: A narrative review106
P035: Establishment of Newly Rapid and Accurate Intra-operative Examination of the Surgical Margin Status in Breast-Conserving Surgery by “Click-to-sense” Assay92
Guide for Authors74
P039: Pathological and clinical insights into postpartum and pregnancy-related breast cancer: Recurrence and tumor characteristics64
P115: Preoperative Localization of Breast Lesions in the Case of Migration of the Stereotactic Biopsy Clip61
P180: Baicalein sensitizes radio-resistant breast cancer cells by downregulating Rac1 signaling59
P079: The impact of pre-operative Oncotype DX Breast Recurrence Scoretesting; the results of the PRE-DX randomised controlled trial51
P104: Primary and Secondary Breast Lymphoma: A Case Series49
P116: HER2 Destiny: Visual scoring using ASCO/CAP guidelines or precise quantification using A.I?49
P067: Construction of the bromodomain-containing protein-associated prognostic model in triple-negative breast cancer46
P078: Impact of the SOUND trial on patient access to breast tumour profiling testing (Oncotype DX) and potential implications for adjuvant treatment decision45
P0102: Precision from pixels: A systematic review and Bayesian network meta-analysis comparing Tomosynthesis and AI-Augmented Mammography in Breast Cancer Detection45
P031: Objective Response to Palbociclib in Combination with Endocrine Therapy for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Real-World Study45
P170: Correlation between expression of p53-mutant, BCL-2 and response to anthracycline-based or taxane-based neoadjuvant chemotherapy in locally advanced breast cancer42
P099: Utility and limitations of ultrasound-guided axillary lymph node fine-needle aspiration cytology in the pretreatment diagnosis of breast cancer39
P287: The Clinical efficacy of the ICG Fluorescence injection technique with blue dye for sentinel lymph node biopsy using dual injection technique in early breast cancer patients38
P149: Management of B3 breast lesions: clinical implications in light of the 2024 EUSOMA guidelines37
P113: Li-Fraumeni: “Genetic testing of Breast/ovarian cancer patients unmask familial pathogenic germline variants in TP53 gene. Clinical implications and family counselling”36
P239: A scoping review of treatments and services in longitudinal care trajectories after initial diagnosis and treatment of breast cancer35
P328: Extent of resection in breast conserving surgery after neoadjuvant chemotherapy: a literature review34
P367: Surgical management of ipsilateral breast cancer recurrence after conservative mastectomy and prepectoral implant reconstruction: exploring the role of wide local excision33
P213: Does response in primary breast cancer correlate with the axillary response after Neo-adjuvant chemotherapy in node-positive disease?32
P182: Post-operative whole breast irradiation lowers mortality in earlystage, luminal A-like, low-risk, older breast cancer patients: an analysis from the EUSOMA database32
P231: Outcomes of triple-negative breast cancer patients who developed thyroid dysfunction following Pembrolizumabcontaining regimens neoadjuvant chemotherapy32
P202: PRIOR-HER2 - Pathologic Response Investigation of Oncologic Regions in HER2 Positive Breast Cancer: PHESGO in Indian setting32
P207: Localization of the Sentinel Lymph Node with a Single Tracer after Neoadjuvant Chemotherapy in Patients with Initial cN+ Diagnosis32
P247: Challenges and Practices in Breast Cancer Surgery: A Nationwide Survey of Surgeons in Bangladesh31
P263: Hormone receptor levels and benefit from prolonged adjuvant tamoxifen therapy in postmenopausal breast cancer31
P243: Partnership Between Breast Oncology Surgical Services and Hyperbaric Oxygen Therapy Unit Reduces Complications And Improves Outcomes31
P264: Survival from ER-positive breast cancer in women who carry a BRCA1 mutation31
P266: Validating an Indian prognostication signature in hormone positive breast cancer patients: A single center experience30
P339: The Utility of the Magnifying Glass Incision in Nipple-Sparing Mastectomy (NSM) and Deep Inferior Epigastric Artery Perforator (DIEP) Flap Breast Reconstruction30
P229: Impact of neoadjuvant chemotherapy on early relapses of luminal stage II breast cancer30
P279: Evaluation of Pathologic Complete Response (pCR) as a Surrogate for Event-Free Survival in neoadjuvant Human Epidermal Growth Factor Receptor 2–Positive (HER2+) Early Breast Cancer (eBC)29
P332: Oncological Safety and Patient Satisfaction of Immediate Lipofilling in Breast-Conserving Surgery: A Systematic Reviewand Subgroup Meta-Analysis Comparing Outcomes with No Lipofilling29
P345: Proportion and surgical management of low- vs. higher-risk breast ductal carcinoma in situ in two oncology centers in Lima, Peru (2016–2023)29
P295: Pilomatrixoma of the breast, a rare lesion simulating breast cancer: a case report29
P383: Re-excision Decisions in Breast Conserving Surgery: How Updated ABS Guidelines Can Lower Re-excision Rates in the UK28
P362: Pedicled pectoralis minor flap for the prevention of arm lymphedema in breast cancer patients undergoing axillary lymph node dissection27
P305: The SLIM Approach: Introducing a novelway for the orientation of cavity shaves during breast conserving surgery in breast cancer patients27
P309: Four Grounds for Choosing Bilateral Free DIEP Flap Breast Reconstruction in Breast Cancer with Large and Ptotic Breasts: a retrospective case-control study26
P387: Current trends in the evaluation of axillary lymph nodes in patients with breast cancer26
P321: Increasing opportunities for breast-conserving therapy in multiple ipsilateral breast cancer: Dutch nationwide study26
P249: Pregnancy Associated Breast Cancer (PABC): Prognostic factors for one versus two pregnancies26
P406: Male breast cancer genetic predisposition, survival data and clinocopathological characteristics: 33-year study from Serbia26
P369: Observation Of Intraoperative Tissue Perfusion Aids In Minimalisation Of Oncoplastic Complications26
P282: Improving pathological complete response assessment methods in breast cancer management: findings from a single-institution analysis25
P241: Physical Examination by a Physician adds little to no Value in Breast Cancer Surveillance25
P254: Impact of high lymph node burden on the development of brain metastases in patients achieved pathological complete response after neoadjuvant chemotherapy in HER2-positive breast cancer25
P458: Enhancing Quality of Life for Early Breast Cancer (EBC) patients in Europe: Early results of a Request for Proposal (RFP)24
P371: Sentinel Lymph Node (SLN) Imaging in Patients with a History of Breast-Conserving Surgery and Sentinel Lymph Node Biopsy for Breast Cancer24
P465: Beyond Breast Cancer; Understanding the spectrum of malignant tumours of non-mammary origin in Breast24
P375: Long-term Outcomes of Sentinel Lymph Node Biopsy and Tailored Axillary Surgery Following Neoadjuvant Chemotherapy for Early Breast Cancer24
P444: Cancer-related cognitive impairment (CRCI) in women with early breast cancer: A prospective screening study prior to and following chemotherapy23
P466: Antitumor immunological benefits of Vitamin E analogue δ-tocotrienol in early breast cancer patients depend on body mass index: results from the TOCANNATO window-of-opportunity trial23
P479: Success rate of ultrasound-guided radiofrequency ablation therapy with surgical excision for breast cancer in Rajavithi hospital22
P468: Pathologic regression and treatment dose intensity in breast cancer patients receiving chemotherapy with or without Viscum album extract injections: a retrospective study22
P443: Factors affecting the formation of Lymphoedema due to Breast Cancer (Is Primary Systemic Treatment an independent factor in the formation of Breast Cancer Related Lymphoedema?)22
P473: Percutaneous Ultrasound-Guided Cryoablation for the Treatment of Breast Cancer in Non-Surgical Patients21
P472: Efficacy of CDK4/6 inhibitors in the treatment of patients with somatic PIK3CA mutation in hormone-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer (HR+/HER2-21
Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy21
P448: Sensitizing Primary healthcare workers towards psychosocial issues in young breast-cancer women: Policy paper for NGOs in developing nations21
P452: Has the Employment of Bromelain and Alpha-Lipoic Acid a Role on Oedema and Seroma Prevention in Breast Conservative Surgery? A Double-Blind Randomized Controlled Trial21
A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort20
Tailored axillary surgery in patients with clinically node-positive breast cancer: Pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)20
Meeting the proposal for service improvement for pregnant women with cancer20
Efficacy of trastuzumab emtansine (T-DM1) and lapatinib after dual HER2 inhibition with trastuzumab and pertuzumab in patient with metastatic breast cancer: Retrospective data from a French multicente20
The continuing conundrum in oligometastatic breast carcinoma: A real-world data20
Seizing the moment: The time for harnessing electronic patient-reported outcome measures for enhanced and sustainable metastatic breast cancer care is now20
Using Radio-Occult Lesion Localization (Roll) Techniques To Identify The Clipped Node In Targeted Axillary Dissections (Tad)19
Title Page19
Surgical Outcomes Of Post-Mastectomy Radiotherapy Following Immediate Prosthetic Breast Reconstruction: Six-Year Experience19
Editorial Board19
General Information19
No association between breast pain and breast cancer19
Reproductive outcomes in young breast cancer survivors treated (15–39) in Ontario, Canada: a population-based study19
Trends in the pre-operative diagnosis and surgical management of axillary lymph node metastases in women with screen-detected breast cancer19
Assessing the Impact of the COVID-19 outbreak on the oncological practice regarding metastatic breast cancer patients treated with CDK4/6 inhibitors18
Totality of evidence for ABP 980, a trastuzumab biosimilar: results of chemo-synergy studies in combination with pertuzumab18
P243 Is the indian population ready for acosog z0011 protocol?18
Line of therapy adjustment in a patient with advanced triple-negative breast cancer (TNBC) by using personalized ctDNA test for treatment response monitoring18
Index17
P255 Breast cancer surgery with ‘pecs block’ technique in the oldest old17
P271 The impact of extraordinary situations such as war on tumor characteristics and time before the start of treatment in patients with non-metastatic breast cancer (BC)17
P277 Sick leave and predictive factors for sick leave at 12 months after breast cancer surgery in the randomized controlled physical activity trial (PhysSURG-B)17
P251 Real-world experience with CDK4/6 inhibitors for metastatic HR+/HER2−breast cancer at a single cancer center17
P273 The lived experiences of telehealth system use among women with breast cancer17
P291 Evolving strategies for the routine follow-up of patients with early breast cancer and the impact of COVID-19: a survey of healthcare providers16
ROLE OF HEMI-BODY RADIATION IN BREAST CANCER WITH DISSEMINATED BONE METASTASIS16
PO100 HER2 LOW METASTATIC BREAST CANCER PATHOLOGICAL AND CLINICAL CHARACTERISTICS: A SINGLE MEXICAN INSTITUTION EXPERIENCE16
P280 How often do breast cancer patients seek traditional Chinese medicine in North China?16
PO81 NURSES AS PATIENT ADVOCATES IN RESOURCE-RESTRICTED COUNTRIES - EXPERIENCE OF GEORGIA16
DOES THE LOCATION OF BRAIN METASTASES AFFECT THE PROGNOSIS IN BREAST CANCER PATIENTS?16
PR86 THE TREATMENT JOURNEY OF ABC PATIENTS IN MOROCCO: NEEDS AND CHALLENGES FROM A PATIENT ‘S PERSPECTIVE, 2 CASE REPORTS16
P289 Retrospective study of pregnancy outcome after breast cancer16
PO85 MEETING THE NEEDS OF WOMEN WITH ADVANCED BREAST CANCER IN THE SUPPORT SETTING16
IMPACT OF THE REGIONAL AND SYSTEMIC TREATMENT IN BREAST CANCER PATIENTS WITH LOCAL RECURRENCE16
P278 Early Integrated Rehabilitation Helped Breast Cancer Patients to Start Healthy Lifestyle– A Comparison Between the Intervention and Control Group in a Prospective Study16
PO103 BRAIN IMAGING SURVEILLANCE IN ASYMPTOMATIC PATIENTS WITH METASTATIC BREAST CANCER: PATIENT AND PHYSICIAN PERSPECTIVES15
PO120 CAN A BREAST CANCER REGISTER MEASURE ADHERENCE TO NATIONAL ADVANCED BREAST CANCER (ABC) TREATMENT GUIDELINES IN CLINICAL PRACTICE?15
EMOTIONAL DISTRESS, BRAIN FUNCTIONING, SOCIAL WELL-BEING AND BIOBEHAVIORAL PROCESSES IN METASTATIC BREAST CANCER PATIENTS: OUTCOMES OF THE DISTRESSBRAIN PROJECT15
PO115 REAL WORLD EFFECTIVENESS OF EVEROLIMUS-BASED THERAPY IN HORMONE-RECEPTOR-POSITIVE METASTATIC BREAST CANCER AFTER PROGRESSION ON CDK4/6 INHIBITOR15
PR131 SACITUZUMAB GOVITECAN – REAL-WORLD EXPERIENCE OF A PORTUGUESE CANCER CENTER14
PO136 IMPACT OF ISOLATED SOLITARY BREAST CANCER LIVER METASTASIS SURGICAL RESECTION ON COMMON PATIENT HEALTH STATUS AND ABILITY TO PROCEED CHEMOTHERAPY14
PR126 ANTIOXIDANT CORRECTION OF HEMATOLOGICAL TOXICITY DURING CHEMOTHERAPY FOR METASTATIC BREAST CANCER14
BP140 UNMASKING THE IMPACT OF INPATIENT PALLIATIVE CARE CONSULTATION ON PATIENT OUTCOMES IN ADVANCED BREAST CANCER PATIENTS: A RETROSPECTIVE REVIEW14
PO118 RESULTS OF ANTI-HER 2 THERAPIES AFTER BRAIN METASTASES ON THE PROGNOSIS IN BREAST CANCER PATIENTS14
PO133 RADIATION INDUCED HYPOTHYROIDISM IN LOCALLY ADVANCED BREAST CANCER14
SABR in oligometastatic breast cancer: Current status and future directions13
PR138 MALIGNANT PHYLLODES TUMOR WITH THIRD LOCAL RECURRENCE AND MULTIPLE DISTANT METASTASES: A CASE REPORT13
Response to Soran et al.13
Analysis of the association of HER-2 low carcinomas and PAM50 assay in hormone receptor positive early-stage breast cancer13
OR139 ENHANCING PATIENT CARE: INTERIM DATA ANALYSIS AND PATIENT EXPERIENCE OF PERSONALIZED ELECTRONIC SYMPTOM MONITORING LED BY A SPECIALIST NURSE FOR ENGAGEMENT IN TREATMENT AND IMPROVED QUALITY OF L13
Nodal response to primary systemic therapy predicts prognosis of cN3c breast cancer patients receiving multimodality therapy13
A randomized, double-blind, single-dose study (LAVENDER) to assess the safety, tolerability, and immunogenicity of ABP 980 and pertuzumab combined in a single infusion in healthy subjects12
P154 Characteristics and prognosis of BRCA-associated breast cancers: Results from a single-center observational study in Thailand12
Effectivness of breast-conserving treatment for minimal residual tumors after neoadjuvant breast cancer therapy12
Implementation of a pathology-supported genetic testing framework for return of research results to family members of deceased breast cancer patients with somatic TP53 variants12
P157 MammaPrint 8-year follow up results in patients with early breast cancer from a single-center Italian cohort study12
Role of time factor between External Beam Radiotherapy alone versus External Beam in combination with brachytherapy boost in breast cancer patients after breast conserving surgery12
One size fits all? Novel pulse biopsy platform offers improved needle control, high tissue yield and multiple needle options – pre-clinical results12
P131 Real World Evidence of the Impact at Neoadjuvant Chemotherapy Treatment on the Prognosis of Patients with Early Breast Cancer12
P171 Do Tumor Infiltrating Lymphocytes and Programmed Cell Death Ligand -1 have a Predictive and Prognostic Role in Advanced Triple Negative Breast Cancers – Results of a Study from a Developing Count12
P184 Unsatisfactory cosmetic results after oncoplastic breast-conserving surgery12
Analysis of primary endocrine therapy in breast cancer patients over 70 years from a single unit in South Africa: analysis of those that choose no surgery first. Highlighting COVID-19 sensitive issues12
P143 Kinetics of Ejection Fraction Decline as A Predictive Factor for Cardiotoxicity in Trastuzumab-treated Early Breast Cancer Patients: Single Institution Experience12
P152 The impact of the TailorX and RxPonder studies and the use of Oncotype Dx in clinical practice: A single Breast Cancer Center experience12
Hospital vs community screening for breast cancer12
P176 Is the ≥1-cm width of resection margin in phyllodes tumor necessary to reduce recurrence?12
Factors affecting sentinel lymph node metastasis in patients with breast cancer undergoing sentinel lymph node biopsy before or after systemic therapy12
Radiation dose distribution in cardiac valves in left-sided breast cancer radiotherapy12
Angiosome theory findings using new protocol of CT-angiography improves outcomes in DIEP-flap reconstruction surgery in breast cancer patients11
The long term outcome of patients on primary endocrine therapy11
CURRENT STANDARD OF CARE FOR HER2+ ABC11
IN18 BIOLOGY 1.0 – INTERPRETING AN NGS REPORT11
Retrospective evaluation of immediate postmastectomy breast reconstruction with Tiloop BRA. Our experience with 103 patients11
P203 Comparing the combine flap fixation and Harmonic scalpel technique with the Harmonic scalpel alone in reducing seroma formation after mastectomy in breast cancer patient: A pilot study for a RCT11
IN27 REVISITING OLIGOMETASTATIC DISEASE11
P191 Skin-sparing or nipple-sparing mastectomy with one-stage or two-stage reconstruction: analysis of early outcomes and patient’s satisfaction11
Abstract Presenters11
IN29 NEW IMAGING TECHNOLOGIES AND STRATEGIES IN ABC11
IN34 OPTIMAL MANAGEMENT OF AN OLDER FRAIL PATIENT WITH ADVANCED BREAST CANCER10
PO54 HOME BASED CARE FOR TERMINAL CANCER PATIENTS: STUDY FROM RURAL PART OF INDIA10
SBRT AND NEW RADIOTHERAPY TECHNIQUES FOR METASTATIC DISEASE10
Editorial Board10
Artificial intelligence for preoperative diagnosis of sentinel lymph node biopsy in early breast cancer.10
SA 6.4 Breast surgery for local recurrence10
PO67 “GUIDING TOWARDS BETTER CARE: BREAST CANCER NAVIGATORS’ PROGRAM IMPLEMENTATION FOR INCREASING PATIENTS’ SATISFACTION AT A COMPREHENSIVE CANCER CENTER”10
GLOBAL SURVEY OF 104 CANCER PATIENT ORGANISATIONS REVEALS DEVASTATING IMPACT OF COVID-1910
BP51 ABC4NURSES: ACO-DESIGN PROJECT TO DEVELOP, DELIVER AND EVALUATE AN ONLINE EDUCATION PROGRAMME FOR NURSING CARING FOR PEOPLE WITH ADVANCED BREAST CANCER10
PO68 “I AM STILL ALIVE”: PEER SUPPORT GROUP FOR OLDER WOMEN WITH METASTATIC BREAST CANCER IN NIGERIA10
French college of gynecologists and obstetricians (CNGOF) recommendations for clinical practice: Place of breast self-examination in screening strategies10
More Breast-Conserving Surgery in Australia in T2 Breast Cancers Over the Last 20 Years10
Title Page10
EFFECTIVE ADVOCACY FOR WOMEN WITH METASTATIC BREAST CANCER: A EUROPEAN PERSPECTIVE10
IN37 INEQUITIES IN ACCESS TO NEW CANCER DRUGS: ROLE OF REGULATORS AND CLINICAL TRIALS10
ADVANCED BREAST CANCER (ABC) PATIENT SUPPORT BY WEB CONFERENCING USING ZOOM10
Preoperative breast MRI influences surgical management in patients with invasive lobular carcinoma10
De-escalation of loco-regional treatments: Time to find a balance10
SA 7.3 Limited axillary surgery concepts to determine nodal pathologic complete response10
A PATIENT’S JOURNEY: BRIDGING THE GAP FROM METASTATIC BREAST CANCER DIAGNOSIS TO ACTIVE INVOLVEMENT AS A PEER NAVIGATOR10
Adjuvant endocrine therapy for pre- and postmenopausal women9
De-escalation of early breast cancer therapy: Umberto Veronesi’s legacy9
Can we prevent brain metastases?9
P004 Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer : a multicenter, open-label, phase 2 trial9
Axillary surgery in node-positive breast cancer9
Accelerating progress from advanced to early breast cancer for TNBC9
SA 8.1 Assessing HER2 heterogeneity9
The contribution of radiation therapy to personalised care of patients with early breast cancer9
P001 Scalp cooling system for breast cancer patients treated by adjuvant or neo-adjuvant chemotherapy9
Integrating CDK 4-6 in the treatment of patients with early breast cancer9
Type/timing of reconstruction when post-mastectomy radiotherapy is planned9
P023 Male breast cancer: a single center report of histopathological sybtypes and outcomes9
SA 9.1 Optimal neoadjuvant and adjuvant therapy for patients with early triple negative breast cancer9
AA2 Overtreatment in early breast cancer – who is at risk?9
Accelerating progress from advanced to early breast cancer (SERDS, PI3Kinhibitors, other novel agents)9
P012 Survival outcomes and toxicities of adjuvant docetaxel-cyclophosphamide for four cycles in node negative triple negative and HER2 positive Chinese breast cancer patients: A 10 year follow up stud9
Neoadjuvant and adjuvant treatment for triple negative breast cancer9
PARP inhibitors in treatment of early stage breast cancer9
Marked reduction in the risk of dementia in patients with breast cancer: a nationwide population-based cohort study8
E-cadherin expression in triple-negative invasive ductal breast carcinoma8
Tolerance and outcome of hypofractionated whole breast irradiation in young women: from controversies to evidence8
Neratinib as extended adjuvant therapy in patients with HER2-positive/HR-positive early breast cancer: German HTA-driven analyses from the ExteNET study8
P031 Preoperative mammocartography and mammometry for the needs of oncoplastic approaches8
P075 Evaluation of personality traits of breast cancer patients in the context of their surgical therapy8
Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via AKT/mTOR signaling pathway8
Tumor angiogenesis: miRNAome abnormalities deregulate expression of angiogenic genes in breast cancer cells and contribute to increased formation of new but imperfect blood vessels8
Single-cell transcriptome sequencing analysis reveals gynaecomastia to breast cancer transition8
P057 Relationship between TP53 mutations and mammographic and ultrasonographic findings in breast cancer8
Single nucleotide polymorphisms rs17335780 and rs11979255 of the epidermal growth factor receptor (EGFR) correlate with tumor size in breast cancer8
Lifestyle and sexual health8
P027 Establishment of a Thai patient-derived breast cancer organoid biobanking for drug screening in a single medical center in Thailand8
P092 Radiation induced hypothyroidism in breast cancer8
Efficacy of fulvestrant in hormone refractory metastatic breast cancer (mBC): a Canadian province experience8
P090 Dosimetric Evaluation of the Heart and Left Anterior Descending Artery Dose in Radiotherapy for Japanese patients with Breast Cancer8
P042 MicroRNA signature abnormalities in breast cancer cells can facilitate overexpression of chemokines and their receptors responsible for recruitment of stromal cells into tumor microenvironment8
P037 EGFR overexpression is related to immunohistochemical biomarkers in breast cancer8
P036 Classification of HER2-negative breast cancers by ERBB2 copy number alteration status reveals molecular differences associated with chromosome 17 gene aberrations8
Expression of RANK-c in ER-/HER2+ breast cancer cells affect aggressiveness through altering the NF-κB equilibrium8
Role of hypofractionated tumor bed boost in the era of short course radiotherapy in early stage breast cancer7
Contraception in breast cancer survivors from the FEERIC case-control study (performed on behalf of the Seintinelles research network)7
Interassay and interobserver comparability study of four programmed death-ligand 1 (PD-L1) immunohistochemistry assays in triple-negative breast cancer7
Prognosis of pregnancy after breast cancer diagnosis according to the type of treatment: A population-based study in Korea by the SMARTSHIP group7
Explaining risks and benefits of loco-regional treatments to patients7
Low neighborhood socioeconomic status is associated with higher mortality and increased surgery utilization among metastatic breast cancer patients7
Editorial Board7
SA 1.3 What’s new in systemic treatment of patients with early breast cancer7
P098 Adjuvant radiotherapy after radical surgery and immediate breast reconstruction7
Effects of IORT and EBRT methods on local recurrence control in breast cancer patients using Weibull regression model7
SL 1 The future of innovation: Why arewe conducting clinical trials in countries that are unlikely to be able to afford innovative drugs?7
Editorial Board7
BRCA1/2 testing for genetic susceptibility to cancer after 25 years: A scoping review and a primer on ethical implications7
PO83 INCLUSION BY DESIGN: RECOMMENDATIONS FOR BUILDING EQUITY IN CLINICALTRIALS THROUGH THE LENS OF METASTATIC BREAST CANCER7
High risk surveillance outcomes in women with breast cancer gene mutations.7
SA 3.1 Understanding the anti-cancer immune response: Innate and adaptive responses to cancer cells7
SA 1.1 Surgery of patients with early breast cancer: Quo vadis?7
P114 Characteristics of residual tumor after neoadjuvant chemotherapy (nact)may predict outcomes in patients with triple negative breast cancer (tnbc)7
SA 4.2 Local treatment in patients with high risk hereditary breast cancer7
Utility of magnetic resonance imaging (MRI) in the management of breast carcinoma7
Digital breast tomosynthesis versus X-ray of the breast specimen for intraoperative margin assessment: A randomized trial7
Nomogram for predicting overall survival in patients with triple-negative apocrine breast cancer: Surveillance, epidemiology, and end results-based analysis7
Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow up7
Axillary lymph node dissection: Dead or still alive?7
SA 2.1 ctDNA dynamics for early assessment of recurrence risk7
Outcome beyond third-line chemotherapy for metastatic triple-negative breast cancer in the French ESME program7
Advancing treatment choices: CDK4/6 inhibitor switching in HR+/HER2- metastatic breast cancer6
Optimising post-operative radiation therapy after oncoplastic and reconstructive procedures6
Novel models based on machine learning to predict the prognosis of metaplastic breast cancer6
Unveiling the future of breast cancer therapy: Cutting-edge antibody-drug conjugate strategies and clinical outcomes6
Correlation between week 24 trastuzumab-dkst response and week 48 progression-free survival: the HERITAGE trial6
Predicting the survival benefit of local surgery in patients aged 70 years or older with stage IV breast cancer: A population-based analysis6
Extracellular volume measured by whole body CT scans predicts chronic cardiotoxicity in breast cancer patients treated with neoadjuvant therapies based on anthracyclines: A retrospective study6
Impacts of clinicopathological factors on efficacy of trastuzumab deruxtecan in patients with HER2-positive metastatic breast cancer6
Exploring breast surgeons’ reasons for women not undergoing immediate breast reconstruction6
Management and outcomes for older women with early breast cancer treated with primary endocrine therapy (PET)6
RE: The cost impact of unselective vs selective MammaPrint testing in early-stage breast cancer in Southern Africa6
Neurocognitive outcomes following fetal exposure to chemotherapy for gestational breast cancer: A Canadian multi-center cohort study6
Comparison of the genomic alterations present in tumor samples from patients with metastatic inflammatory versus non-inflammatory breast cancer reveals AURKA as a potential treatment target6
Editorial Board6
Targeted therapeutic strategies for Nectin-4 in breast cancer: Recent advances and future prospects6
Preoperative non-palpable breast lesion localization, innovative techniques and clinical outcomes in surgical practice: A systematic review and meta-analysis6
Psychometric properties of patient-reported outcomes Common Terminology Criteria for adverse events (PRO-CTCAE®) in breast cancer patients: The prospective observational multicenter VIP study6
Safety of pre- or postoperative accelerated radiotherapy in 5 fractions: A randomized pilot trial6
The efficacy and safety of paclitaxel plus bevacizumab therapy in breast cancer patients with visceral crisis6
Assessment and reimbursement of gene expression tests in breast cancer in Europe – a comparative policy analysis6
Breast magnetic resonance imaging as a problem solving tool in women recalled at biennial screening mammography: A population-based study in the Netherlands6
0.10622906684875